These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9351744)

  • 1. Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade.
    Nanthakumar K; Newman D; Paquette M; Greene M; Rakovich G; Dorian P
    Am Heart J; 1997 Oct; 134(4):752-7. PubMed ID: 9351744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators.
    Taneda K; Aizawa Y;
    Pacing Clin Electrophysiol; 2001 Nov; 24(11):1602-6. PubMed ID: 11816628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; Rosenfeld L; Batsford W; Lee F; McPherson C
    Circulation; 1994 Jul; 90(1):241-7. PubMed ID: 8026004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy.
    Behrens S; Ehlers C; Brüggemann T; Ziss W; Dissmann R; Galecka M; Willich SN; Andresen D
    Clin Cardiol; 1997 Mar; 20(3):253-7. PubMed ID: 9068912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers for ventricular arrhythmias: have we underestimated their value?
    Campbell TJ
    Aust N Z J Med; 1996 Oct; 26(5):689-96. PubMed ID: 8958366
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
    Cohen MB; Snow JS; Merkatz KA; Kholwadwala D; Jadonath RL; Goldner BG; Cohen TJ
    Am Heart J; 1996 Aug; 132(2 Pt 1):446-9. PubMed ID: 8701909
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and management of ventricular tachycardia.
    Naik N; Talwar KK
    J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.
    Pokorney SD; Mi X; Hammill BG; Allen LaPointe NM; Curtis LH; Al-Khatib SM
    Am J Cardiol; 2017 May; 119(9):1401-1406. PubMed ID: 28341360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).
    Behrens S; Ney G; Fisher SG; Fletcher RD; Franz MR; Singh SN
    Am J Cardiol; 1997 Jul; 80(1):45-8. PubMed ID: 9205018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia].
    Lü HS; He BB; Huang GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1240-2. PubMed ID: 19726373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation.
    Wiesfeld AC; Crijns HJ; Tuininga YS; Lie KI
    Pacing Clin Electrophysiol; 1996 Jul; 19(7):1026-35. PubMed ID: 8823828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian pattern of spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
    Eksik A; Akyol A; Norgaz T; Aksu H; Erdinler I; Cakmak N; Alper AT; Cinar B; Yildirim A; Gürkan K
    Med Sci Monit; 2007 Sep; 13(9):CR412-416. PubMed ID: 17767121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential proarrhythmic effect of biventricular pacing: fact or myth?
    Shukla G; Chaudhry GM; Orlov M; Hoffmeister P; Haffajee C
    Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-peaking circadian variation in the occurrence of sustained supraventricular tachyarrhythmias.
    Kupari M; Koskinen P; Leinonen H
    Am Heart J; 1990 Dec; 120(6 Pt 1):1364-9. PubMed ID: 1978978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.